Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Ten teams are being recognized for their proof-of-concept ideas following Phase 1 of the Data Sharing Index (“S-Index”) Challenge, an NIH competition aimed at incentivizing data sharing
Research funded by the National Eye Institute has identified the signaling mechanism that triggers steroid-induced glaucoma by creating a 3D “eye-on-a-chip” platform that mimics the flow of ocular fluids.
New research funded by the National Eye Institute at the University of California, Los Angeles has uncovered details about the muscle that controls blinking, offering a pathway toward developing blink-assisting prostheses.
A new study spearheaded by investigators at Scripps Research and the National Eye Institute offers compelling evidence that vision loss from macular telangiectasia can be slowed with a neuroprotective surgical implant.
During most eye infections or injuries, neutrophils, immune cells found in the blood, are usually the first line of defense. However, new research shows retina responds differently than other tissues in the body.
A National Eye Institute-funded research team at the University of Minnesota Medical School discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels.
A new study funded by the National Eye Institute shows that certain retinal cells can rewire themselves when vision begins to deteriorate in retinitis pigmentosa, a genetic eye disease that leads to progressive blindness.
Scientists have long known that the brain’s visual system isn’t fully hardwired from the start—it becomes refined by what babies see—but the authors of a new study still weren’t prepared for the degree of rewiring they observed.
A new National Eye Institute-supported study identifies a possible way to slow or block progression of age-related macular degeneration (AMD), a leading cause of blindness in people over age 50.